AMP945 shows improved selectivity compared to competitor agents – e.g. defactinib
And there’s the demonstration of the difference between the two
Nice work SB ...
.
Ann: Amplia and Garvan Institute Enter Collaboration Agreement, page-12
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.21M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.5¢ | 14.5¢ | $83.61K | 528.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 68334 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 60177 | 1 |
View Market Depth
| Last trade - 16.10pm 07/10/2024 (20 minute delay) ? |
| ATX (ASX) Chart |